2006 Alabama Code - Chapter 2 — CONTROLLED SUBSTANCES.

Article 1 General Provisions.

• Section 20-2-1 — Short title.
• Section 20-2-2 — Definitions.
• Section 20-2-3 — Immunity of persons reporting suspected use, etc., of controlled substance by minor child.

Article 2 Standards and Schedules.

• Section 20-2-20 — Administration of chapter.
• Section 20-2-21 — Nomenclature of controlled substances in schedules.
• Section 20-2-22 — Schedule I - Standards for compilation.
• Section 20-2-23 — Schedule I - Listing of controlled substances.
• Section 20-2-24 — Schedule II - Standards for compilation.
• Section 20-2-25 — Schedule II - Listing of controlled substances.
• Section 20-2-26 — Schedule III - Standards for compilation.
• Section 20-2-27 — Schedule III - Listing of controlled substances.
• Section 20-2-28 — Schedule IV - Standards for compilation.
• Section 20-2-29 — Schedule IV - Listing of controlled substances.
• Section 20-2-30 — Schedule V - Standards for compilation.
• Section 20-2-31 — Schedule V - Listing of controlled substances.
• Section 20-2-32 — Revision and republication of schedules.

Article 3 Regulation of Manufacture and Distribution.

• Section 20-2-50 — Certifying boards to promulgate rules and charge reasonable fees for registration and administration of provisions relating to manufacture, etc., of controlled substances; disposition of fees collected.
• Section 20-2-51 — Registration of persons manufacturing, distributing or dispensing controlled substances - General requirements.
• Section 20-2-52 — Registration of persons manufacturing, distributing or dispensing controlled substances - Standards; requirements as to practitioners conducting research; effect of federal registration.
• Section 20-2-53 — Registration of persons manufacturing, distributing or dispensing controlled substances - Order to show cause; proceedings; review; issuance of stay.
• Section 20-2-54 — Registration of persons manufacturing, distributing or dispensing controlled substances - Revocation or suspension of registration - Grounds and procedure generally.
• Section 20-2-54.1 — Rules and regulations.
• Section 20-2-55 — Registration of persons manufacturing, distributing or dispensing controlled substances - Revocation or suspension of registration - Suspension without prior order to show cause.
• Section 20-2-56 — Maintenance of records and inventories by registrants generally.
• Section 20-2-57 — Distribution of certain controlled substances by one registrant to another registrant.
• Section 20-2-58 — Dispensing of controlled substances in Schedule II; maintenance of records and inventories by registered pharmacies.

Article 4 Offenses and Penalties.

• Section 20-2-71 — Prohibited acts B.
• Section 20-2-72 — Prohibited acts C.
• Section 20-2-74 — Prescription, administration, etc., of controlled substances by practitioners of veterinary medicine for use of human beings or by practitioners of dentistry for persons not under treatment in regular practice of profession.
• Section 20-2-78 — Penalties imposed for violations of chapter in addition to other civil or administrative penalties or sanctions.

Article 4A Trafficking in Illegal Drugs.

Article 5 Enforcement.

• Section 20-2-90 — State Board of Pharmacy, Department of Public Safety, etc., to enforce chapter; drug inspectors to meet minimum standards.
• Section 20-2-91 — Inspection of stocks of controlled substances and prescriptions, orders, etc., required by chapter; disclosure of information as to prescriptions, orders, etc., by enforcement personnel.
• Section 20-2-92 — Injunctions.
• Section 20-2-93 — Forfeitures; seizures.

Article 6 Therapeutic Research.

• Section 20-2-110 — Short title.
• Section 20-2-111 — Legislative findings; cannabis research.
• Section 20-2-112 — Definitions.
• Section 20-2-113 — Controlled Substances Therapeutic Research Program - Established; review committee; rules and regulations; formulation with federal agencies.
• Section 20-2-114 — Controlled Substances Therapeutic Research Program - Limited to cancer chemotherapy and glaucoma patients; certification; exemption from prosecution.
• Section 20-2-115 — Composition of review committee.
• Section 20-2-116 — Certification in subspecialty of oncology required; certification by State Board of Medical Examiners; recertification.
• Section 20-2-117 — Contracts for receipt of cannabis; Board of Medical Examiners to promulgate guidelines, rules and regulations.
• Section 20-2-118 — Annual reports to Governor and Legislature.
• Section 20-2-119 — Enumeration as Schedule I or II substance inapplicable.
• Section 20-2-120 — Penalties.

Article 7 Imitation Controlled Substances.

• Section 20-2-140 — Short title.
• Section 20-2-141 — Definitions.
• Section 20-2-142 — Legislative intent.
• Section 20-2-143 — Manufacture, distribution, possession, or advertisement of imitation controlled substances prohibited; penalties; immunity of certain persons from liability.
• Section 20-2-144 — Exceptions.

Article 8 Solicitation, Attempt and Conspiracy to Commit Controlled Substance Crime.

Article 9 Precursor Chemicals.

• Section 20-2-180 — Definitions.
• Section 20-2-181 — Board to designate by rule listed precursor chemicals; interim list established.
• Section 20-2-182 — License required for furnishing listed precursor chemical; licensing procedure; content of license; record of transactions.
• Section 20-2-183 — Permit for possession; requirements to receive permit; copies.
• Section 20-2-184 — Denial, suspension or revocation of license.
• Section 20-2-185 — Reporting transactions - Board to supply form.
• Section 20-2-186 — Procedure upon discovery of loss or theft of chemicals - Records - Audits and inspections of records.
• Section 20-2-187 — Adoption of rules; administrative fees authorized.
• Section 20-2-188 — Exceptions to requirements for sale or transfer of chemicals, and to licensing requirements.
• Section 20-2-189 — Property rights in chemicals forfeited upon violation.
• Section 20-2-190 — Penalties; sale of ephedrine, etc.; Alabama Methamphetamine Abuse Task Force.

Article 10 Controlled Substances Prescription Database.

• Section 20-2-210 — Legislative findings.
• Section 20-2-211 — Definitions.
• Section 20-2-212 — Controlled substances prescription database program; powers and duties of department; trust fund.
• Section 20-2-213 — Reporting requirements.
• Section 20-2-214 — Limited access to database permitted for certain persons or entities.
• Section 20-2-215 — Confidentiality of database.
• Section 20-2-216 — Unauthorized disclosure of information; unauthorized access, alteration, or destruction of information.
• Section 20-2-217 — Surcharge on controlled substance registration certificate for maintenance, etc., of database.
• Section 20-2-218 — Reimbursement of certain costs incurred in compliance with article.
• Section 20-2-219 — Financing of development, operation, etc., of database.
• Section 20-2-220 — Liability for reporting.